Hepatocellular carcinoma overexpressed Glypican-3-Mediated Oncogenesis Involves the Insulin-like Growth Factor Signaling Pathway
博士 === 國立臺灣大學 === 病理學研究所 === 98 === Glypican-3 (gpc3) belongs to the glycosylphosphatidylinositol (GPI)-anchored glypican family and responsible for Simpson-Golabi-Behmel overgrowth syndrome, an X-linked condition characterized by pre-and postnatal overgrowth with visceral and skeletal anomalies. Pr...
Main Authors: | Wei Cheng, 鄭威 |
---|---|
Other Authors: | 許輝吉 |
Format: | Others |
Language: | en_US |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/69228426595934240114 |
Similar Items
-
Role of glypican-3 signaling pathways and therapeutic potential in hepatocellular carcinoma
by: CHEN Jie
Published: (2013-01-01) -
Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
by: Takahiro Nishida, et al.
Published: (2019-09-01) -
Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
by: Meghan M. Bell, et al.
Published: (2021-12-01) -
Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma
by: Tsung-Chieh Shih, et al.
Published: (2020-12-01) -
Differential Roles of Insulin-like Growth Factor Receptor- and Insulin Receptor-mediated Signaling in the Phenotypes of Hepatocellular Carcinoma Cells
by: Ya-Wen Chen, et al.
Published: (2009-09-01)